AlphAIalphai — Financial news for AI agents
SEC EDGARMAY 272 min read$FRPT

Cyr William B. sold $221K of FRPT (indirect holdings)

Cyr William B. (Chief Executive Officer) sold 4,319 indirectly-held shares of Freshpet, Inc. (FRPT) at $51.18 ($0.22M total) across 3 trades on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cyr William B.
Published May 27, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$FRPT
Neutral
high confidence
Mentioned
$FRPT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRPTNeutralLow
01

Why it matters

The disclosed fact is the sale size, price ($51.18), and post-transaction holdings (56,121 shares). Because it is pre-arranged, it is more consistent with planned diversification or liquidity than with new negative information.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 designation makes it less actionable as a fundamental catalyst.

03

What to watch

The transaction is indirect and pre-arranged; without additional context (e.g., total insider activity over time), the signal quality is limited.

Relevance 3/10Novelty 3/10Timing: Filed 2026-05-27, disclosing a 2026-05-22 sale under a 10b5-1 plan.

Background

The article is an SEC Form 4 insider transaction disclosure for Freshpet, Inc. (FRPT) by CEO Cyr William, marked as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$FRPTNeutralHigh confidence
Context

Freshpet CEO Cyr William sold $221,046 of FRPT shares via a 10b5-1 plan, with 4,319 shares sold at $51.18.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly marked as a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Sector

No clear sector read-through from a single CEO 10b5-1 sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated insider selling can still coincide with valuation or liquidity needs, so traders may watch for follow-on selling patterns.

Key entities

  • issuer
    Freshpet, Inc.

    Company whose CEO insider sale is disclosed on SEC Form 4.

  • insider
    Cyr William B.

    CEO and officer/director who sold FRPT shares under a 10b5-1 plan.

Read at source← All news

Related articles

AUG 8
$FRPTMed

Freshpet (FRPT) Is Up 12.4% After Raising 2026 Sales Outlook And Margins Improving - Has The Bull Case Changed?

Freshpet (FRPT) shares rose 12.4% after the company reported Q2 sales of $305.59 million and net income of $19.49 million, with improved year-to-date profitability and EPS. Freshpet said a shift toward loyal “MVP” households and higher adjusted gross margin supported lifting 2026 sales growth guidance to 10% to 12%, and it completed an $86.5 million share repurchase.

simplywall.st4 min
AUG 7
$FRPTHighAI 9/10

Freshpet CEO says company delivered its strongest growth rate in more than a year, as company announces 2nd quarter results

Freshpet reported Q2 2026 net sales up 15.5% to $305.6 million and gross profit of $128.7 million, 42.1% of sales. Net income rose to $19.5 million. CEO Billy Cyr cited stronger growth and highest adjusted gross margin since Q1 2020. The company updated 2026 guidance to 10% to 12% net sales growth and $210 million to $220 million adjusted EBITDA.

wfmz.com6 min
AUG 5
$FRPTHighAI 9/10

Why Are Freshpet (FRPT) Shares Soaring Today

Freshpet (FRPT) shares rose 12.7% after the company reported strong Q2 2026 results. Net sales were $305.6 million, up 15.5% year over year and above the $292.3 million consensus. EPS was $0.39 versus $0.22 expected. Adjusted EBITDA and a full-year adjusted EBITDA forecast midpoint of $215 million also beat estimates.

financialcontent.com6 min
AUG 5
$FRPTMed

Freshpet Q2 Earnings Call Highlights

Freshpet (FRPT) said its low-end sales outlook assumes stable macro conditions, while hitting the high end would require stronger advertising, omnichannel gains, more distribution, faster category growth, and a return of trade-up. Q2 adjusted gross margin rose 170 bps to 48.6%. 2026 adjusted gross margin improvement guidance increased to 100 to 150 bps at the midpoint. Operating cash flow rose 31% to $44.4M; free cash flow was $14.7M.

yahoo.com6 min
AUG 5
$FRPTMedAI 8/10

Freshpet’s (NASDAQ:FRPT) Q2 CY2026: Strong Sales, Stock Soars

Freshpet (NASDAQ:FRPT) reported Q2 CY2026 results. Revenue rose 15.5% year on year to $305.6 million, exceeding Wall Street estimates by 4.5%, and GAAP profit was $0.39 per share, 73.6% above consensus. The article also cites analyst expectations for 7.1% revenue growth over the next 12 months and notes the stock rose 7.6% to $67.10 after the report.

financialcontent.com4 min
AUG 5
$FRPTHighAI 9/10

Freshpet, Inc. Reports Second Quarter 2026 Financial Results

Freshpet (Nasdaq: FRPT) reported Q2 2026 net sales of $305.6M, up 15.5% year over year, with gross margin at 42.1% and adjusted gross margin at 48.6%. Net income rose to $19.5M and adjusted EBITDA to $52.2M. The company raised 2026 net sales growth to 10% to 12% and adjusted EBITDA to $210M to $220M, and updated long-term adjusted gross margin to at least 49%.

finanznachrichten.de6 min